Home
Mark Schoenberg, Chief Medical Officer: UroGen Pharma URGN Sell · Filed 06/09
Trade details
- Type
- Insider sale
- Amount
- $142,560.6
- Shares · price
- 5,222 sh · $27.30 a share
- Held after
- 139,763 sh
- Stock
- UroGen Pharma URGN
- Trade date
- 26/06/08
- Filed
- 26/06/09
- Days to filing
- 1 days
Sold 3.6% of holdings
- Share of holding sold
- 3.6%
UroGen Pharma trades, last 26 weeks
What else happened in UroGen Pharma around then
Filed or reported within 30 days of the trade day · 05/09~07/08Mark Schoenberg's recent trades
- Mark Schoenberg
Planned saleUroGen Pharma
Planned saleUroGen Pharma
URGN
$38.4K
871 sh
$38.4K
Filed 09/09
Traded 09/08
- Mark Schoenberg
Planned saleUroGen Pharma
Planned saleUroGen Pharma
URGN
$2.9M
60,677 sh
$2.9M
Filed 08/20
Traded 08/20
- Mark Schoenberg
Planned sale10b5-1 planUroGen Pharma
Planned sale10b5-1 planUroGen Pharma
URGN
$400K
10,000 sh
$400K
Filed 07/09
Traded 07/09
- Mark Schoenberg
Sell10b5-1 planUroGen Pharma
Sell10b5-1 planUroGen Pharma
URGN
$350.1K
10,000 sh
$350.1K
Filed 06/24
Traded 06/22
- Mark Schoenberg
Planned sale10b5-1 planUroGen Pharma
Planned sale10b5-1 planUroGen Pharma
URGN
$350.1K
10,000 sh
$350.1K
Filed 06/22
Traded 06/22